FDA
-
-
-
-
-
-
-
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects
-
-
-
-
-
-
-
Labcorp launches companion diagnostic for ovarian cancer treatment
-
-
-
-
-
-
-
Labcorp Declares Quarterly Dividend
-
-
-
-
-
-
-
Labcorp launches FDA-cleared Alzheimer's blood test for primary care
-
-
-
-
-
-
-
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk
-
-
-
-
-
-
-
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
-
-
-
-
-
-
-
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
-
326,122 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

